Loading…
Wednesday September 16, 2026 4:30pm - 5:15pm EDT
What should Enterprise CI actually be responsible for? 
 


  • Define how enterprise competitive intelligence differs from brand-, asset-, and therapeutic area-focused intelligence—and where each creates the greatest value 

  • Examine how macro trends, disruptive technologies, policy changes, and competitive shifts are reshaping long-term portfolio and enterprise strategy 

  • Explore how enterprise intelligence partners with commercial, R&D, portfolio strategy, business development, and executive leadership to connect insights across the organization 

  • Identify which strategic questions are best answered by enterprise intelligence versus brand- and asset-level teams 
Moderators
avatar for Veronica Granatiero, PharmD, Ph.D.

Veronica Granatiero, PharmD, Ph.D.

Associate Director, Oncology Competitive Intelligence, BMS

Speakers
avatar for Olesya Levsh	​​​​

Olesya Levsh ​​​​

Senior Director, Competitive Intelligence, Cullinan Therapeutics, Inc.

avatar for Hezekiah Blake

Hezekiah Blake

Senior Director, Competitive Intelligence, Amgen

avatar for Jordan Lord

Jordan Lord

Enterprise Competitive Intelligence Lead, AbbVie
Wednesday September 16, 2026 4:30pm - 5:15pm EDT
Junior Ballroom D

Log in to save this to your schedule, view media, leave feedback and see who's attending!

Share Modal

Share this link via

Or copy link